A Randomized Trial of 24 Versus 48 Weeks of Peginterferon Α-2a in Patients Infected With Chronic Hepatitis C Virus Genotype 2 or Low Viral Load Genotype 1: A Multicenter National Study in Japan

Hepatology International - India
doi 10.1007/s12072-009-9134-1
Full Text
Abstract

Available in full text

Categories
Hepatology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Randomized Trial of Peginterferon Alfa-2b and Ribavirin for 48 or 72 Weeks in Patients With Hepatitis C Virus Genotype 1 and Slow Virologic Response

Hepatology
MedicineHepatology
2010English

A Randomized, Controlled Study of Peginterferon Lambda-1a/Ribavirin ± Daclatasvir for Hepatitis C Virus Genotype 2 or 3

SpringerPlus
Multidisciplinary
2016English

Quantification of Hepatitis C Virus (HCV) RNA in a Multicenter Study: Implications for Management of HCV Genotype 1-Infected Patients

Journal of Clinical Microbiology
Microbiology
2009English

Randomized Controlled Trial of Consensus Interferon With or Without Zinc for Chronic Hepatitis C Patients With Genotype 2

World Journal of Gastroenterology
MedicineGastroenterology
2006English

Randomized Trial of Combined Triple Therapy Comprising Two Types of Peginterferon With Simeprevir in Patients With Hepatitis C Virus Genotype 1b

Hepatology Research
HepatologyInfectious Diseases
2016English

Daclatasvir and Sofosbuvir With Ribavirin for 24 Weeks in Chronic Hepatitis C Genotype-3-Infected Patients With Cirrhosis: A Phase III Study (ALLY-3C)

Antiviral Therapy
Infectious DiseasesPharmacology
2018English

Peginterferon Alfa-2a in Patients With Chronic Hepatitis C and Cirrhosis

New England Journal of Medicine
Medicine
2000English

Pharmacist Intervention in Treatment of Patients With Genotype 1 Chronic Hepatitis C

Journal of Managed Care Pharmacy
2009English

Dysregulation of Innate Immunity in Hepatitis C Virus Genotype 1 IL28B-unfavorable Genotype Patients: Impaired Viral Kinetics and Therapeutic Response

Hepatology
MedicineHepatology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy